Insider trades
Ramtin Agah, Chief Officer of RenovoRx RNXT, has filed 13 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $56K. The latest trade was on 04/03.
Ramtin Agah
Chief Medical Officer
- Company
- RenovoRx RNXT
- First filing
- 23/03/29
- Trades
- 21 trades
- Buys / sales
- 13 / 0
- 12-month net buying
- $56K
- Last trade
- 04/03
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
RenovoRxRNXT | Open-market buy | 01/21 | 01/22 | 10,000 sh | $1.00 | $10,000 | +1.3% |
RenovoRxRNXT | Open-market buy | 25/12/31 | 01/05 | 9,795 sh | $0.86 | $8,423.7 | +1.3% |
RenovoRxRNXT | Open-market buy | 25/12/30 | 01/02 | 205 sh | $0.83 | $170.15 | +0.0% |
RenovoRxRNXT | Open-market buy | 25/12/16 | 25/12/17 | 12,000 sh | $0.85 | $10,200 | +1.6% |
RenovoRxRNXT | Open-market buy | 25/12/05 | 25/12/08 | 10,000 sh | $0.96 | $9,600 | +1.3% |
RNXT | Open-market buy | 25/11/21–25/11/24 | 25/11/24 | 22,000 sh2 trades | $0.80avg. | $17,600 | +3.0% |
RenovoRxRNXT | Open-market buy | 25/06/05 | 25/06/09 | 21,000 sh | $1.40 | $29,400 | +2.9% |
RenovoRxRNXT | Open-market buy | 25/04/15 | 25/04/17 | 15,000 sh | $0.90 | $13,500 | +1.4% |
RenovoRxRNXT | Open-market buy | 25/04/11 | 25/04/14 | 20,000 sh | $0.80 | $16,000 | +1.9% |
RenovoRxRNXT | Open-market buy | 25/04/09 | 25/04/10 | 30,000 sh | $0.81 | $24,300 | +2.9% |
RenovoRxRNXT | Open-market buy | 25/04/08 | 25/04/09 | 26,000 sh | $0.84 | $21,840 | +2.5% |
RenovoRxRNXT | Open-market buy | 24/01/26 | 24/01/30 | 40,983 sh | In footnote | No stated value | +632.7% |